Select all the dates you'd like to sign-up for and click "Sign Up"
Managed Care Review Board®: New Guidelines, Treatment Options, and Benefit Management Strategies for Eosinophilic Esophagitis
|
Jointly provided by
This activity is supported by independent educational grants from Regeneron Pharmaceuticals, Inc, Sanofi, and Takeda Pharmaceuticals U.S.A., Inc.